0001543053-17-000001.txt : 20170123 0001543053-17-000001.hdr.sgml : 20170123 20170123155704 ACCESSION NUMBER: 0001543053-17-000001 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170120 FILED AS OF DATE: 20170123 DATE AS OF CHANGE: 20170123 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ARGOS THERAPEUTICS INC CENTRAL INDEX KEY: 0001105533 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 562110007 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4233 TECHNOLOGY DR CITY: DURHAM STATE: NC ZIP: 27704 BUSINESS PHONE: 9192876300 MAIL ADDRESS: STREET 1: 4233 TECHNOLOGY DR CITY: DURHAM STATE: NC ZIP: 27704 FORMER COMPANY: FORMER CONFORMED NAME: MERIX BIOSCIENCE INC DATE OF NAME CHANGE: 20000207 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Harrelson Lori R. CENTRAL INDEX KEY: 0001543053 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35443 FILM NUMBER: 17541049 MAIL ADDRESS: STREET 1: 4233 TECHNOLOGY DRIVE CITY: DURHAM STATE: NC ZIP: 27704 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2017-01-20 0 0001105533 ARGOS THERAPEUTICS INC ARGS 0001543053 Harrelson Lori R. 4233 TECHNOLOGY DRIVE DURHAM NC 27704 0 1 0 0 Vice President Finance Common Stock 2017-01-20 4 A 0 3694 0 A 33699 D Stock Option (right to buy) 5.05 2017-01-20 4 A 0 50000 0 A 2027-01-19 Common Stock 50000 50000 D This option was granted on January 20, 2017 and vests as to 25% of the shares underlying this option on January 1, 2018, with the remaining 75% of the shares underlying this option vesting in equal amounts monthly over the next three years beginning January 1, 2018. /s/ Lori R. Harrelson 2017-01-23